Comparison of aripiprazole and other atypical antipsychotics for pediatric bipolar disorder: A retrospective chart review of efficacy and tolerability

Clinical Psychopharmacology and Neuroscience

Volumn 11, Issue 2, 2013, Pages 72-79

  Oh, Jooyoung ^a   Chang, Jhin Goo ^a   Lee, Seul Bi ^a   Song, Dong Ho ^a   Cheon, Keun Ah ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Antipsychotic agents; Aripiprazole; Bipolar disorder; Child psychiatry

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; PALIPERIDONE; QUETIAPINE; RISPERIDONE;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CHILD; CHILDHOOD DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PEDIATRIC; PEDIATRIC BIPOLAR DISORDER; PRESCHOOL CHILD; SCHOOL CHILD; UNSPECIFIED SIDE EFFECT;

EID: 84883648583     PISSN: 17381088     EISSN: 20934327     Source Type: Journal    
DOI: 10.9758/cpn.2013.11.2.72     Document Type: Article

References (25)

1. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry 2000;48:458-466.
2. Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry 2010;71:864-872.
3. Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, et al STEP-BD Investigators. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2004;55:875-881. (Pubitemid 38526299)
4. Leverich GS, Post RM, Keck PE Jr, Altshuler LL, Frye MA, Kupka RW, et al. The poor prognosis of childhood-onset bipolar disorder. J Pediatr 2007;150:485-490. (Pubitemid 46628810)
5. McClellan J, Kowatch R, Findling RL; Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007;46:107-125.
6. Smarty S, Findling RL. Psychopharmacology of pediatric bipolar disorder: a review. Psychopharmacology (Berl) 2007;191:39-54. (Pubitemid 46294946)
7. Pavuluri MN, Henry DB, Devineni B, Carbray JA, Naylor MW, Janicak PG. A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2004;43:859-867. (Pubitemid 38808491)
8. Correll CU. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry 2008;69(Suppl 4):26-36.
9. Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE Jr. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 2006;67:509-516. (Pubitemid 43764227)
10. Joshi G, Petty C, Wozniak J, Faraone SV, Doyle R, Georgiopoulos A, et al. A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder. J Affect Disord 2012;136:1143-1153.
11. Barzman DH, DelBello MP, Kowatch RA, Gernert B, Fleck DE, Pathak S, et al. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. J Child Adolesc Psychopharmacol 2004;14:593-600.
12. Biederman J, McDonnell MA, Wozniak J, Spencer T, Aleardi M, Falzone R, et al. Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectr 2005;10:141-148. (Pubitemid 40327779)
13. Findling RL, Youngstrom EA, McNamara NK, Stansbrey RJ, Wynbrandt JL, Adegbite C, et al. Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder. J Clin Psychiatry 2012;73:57-63.
14. Yoo HK, Choi SH, Park S, Wang HR, Hong JP, Kim CY. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders. J Clin Psychiatry 2007;68:1088-1093. (Pubitemid 47340331)
15. Kim JW, Park KH, Cheon KA, Kim BN, Cho SC, Hong KE. The child behavior checklist together with the ADHD rating scale can diagnose ADHD in Korean community-based samples. Can J Psychiatry 2005;50:802-805.
16. Conners CK, Barkley RA. Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 1985;21:809-843.
17. Geller B, Tillman R, Bolhofner K, Zimerman B. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry 2008;65:1125-1133.
18. Duax JM, Youngstrom EA, Calabrese JR, Findling RL. Sex differences in pediatric bipolar disorder. J Clin Psychiatry 2007;68:1565-1573. (Pubitemid 350073407)
19. Escamilla I, Wozniak J, Soutullo CA, Gamazo-Garrán P, Figueroa-Quintana A, Biederman J. Pediatric bipolar disorder in a Spanish sample: results after 2.6years of follow-up. J Affect Disord 2011;132:270-274.
20. Kubacki A. Male and female mania. Can J Psychiatry 1986;31:70-72. (Pubitemid 16164794)
21. Wilens TE, Biederman J, Forkner P, Ditterline J, Morris M, Moore H, et al. Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar disorder. J Child Adolesc Psychopharmacol 2003;13:495-505. (Pubitemid 38174239)
22. Arnold LE, Demeter C, Mount K, Frazier TW, Youngstrom EA, Fristad M, et al. Pediatric bipolar spectrum disorder and ADHD: comparison and comorbidity in the LAMS clinical sample. Bipolar Disord 2011;13:509-521.
23. Joshi G, Biederman J, Wozniak J, Doyle R, Hammerness P, Galdo M, et al. Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder. CNS Neurosci Ther 2012;18:28-33.
24. Zeni CP, Tramontina S, Ketzer CR, Pheula GF, Rohde LA. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. J Child Adolesc Psychopharmacol 2009;19:553-561.
25. Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res 2003;61:123-136. (Pubitemid 36513927)